Cleared Special

K261886 - VIVO (9002)

K261886 is an FDA 510(k) clearance for VIVO (9002), manufactured by Catheter Precision, Inc.. The device is a Class 2 Cardiovascular device with product code DQK cleared through the Special 510(k) pathway after a 147-day FDA review.

K261886 · Catheter Precision, Inc. · Cardiovascular device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Oct 2026
Decision
147d
Days
Class 2
Risk

K261886 is an FDA 510(k) clearance for the VIVO (9002). Classified as Computer, Diagnostic, Programmable (product code DQK), Class II - Special Controls.

Submitted by Catheter Precision, Inc. (Fort Mill, US). The FDA issued a Cleared decision on October 30, 2026 after a review of 147 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1425 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

FDA 510(k) Submission Details - K261886

510(k) Number K261886 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 05, 2026
Decision Date October 30, 2026
Days to Decision 147 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
22d slower than avg
Panel avg: 125d · This submission: 147d
Pathway characteristics
Modification to existing cleared device.

DQK Device Classification - Class 2, Special Controls

Product Code DQK Computer, Diagnostic, Programmable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQK Computer, Diagnostic, Programmable

All 437
Devices cleared under the same product code (DQK) and FDA review panel - the closest regulatory comparables to K261886.
PulseAPI SmartWatch
K254226 · PulseAI, Ltd. · Oct 2026
STAR Apollo™ Mapping System
K263380 · Rhythm AI, Ltd. · Oct 2026
Intra-Operative Positioning System (IOPS) and IOPS Visionary System
K263016 · Centerline Biomedical · Oct 2026
EnSite™ X EP System
K261729 · Abbott Medical · Sep 2026
AVVIGO™+ Multi-Modality Guidance System
K253692 · Boston Scientific · Aug 2026
Affera Integrated Mapping System
K262005 · Medtronic, Inc. · Aug 2026
K261886 · VIVO (9002)
Download PDF FDA Summary Catheter Precision, I…